Published in Obesity and Diabetes Week, December 1st, 2003
The home-use trial involved 102 subjects at seven clinical sites. Sixty percent of the subjects had type 1 diabetes and 40% had type 2 diabetes. The age of the subjects ranged from 13 to 71 years with an average age of 46 years. The subjects alternated the insertion site for the 3-day disposable sensor between the arm and abdomen over a 21-day period.
The first sensor insertion was done by a clinician and subsequent insertions were...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.